CERO
Phoenix Biotech Acquisition Corp, CL-A Common Stock
Phoenix Biotech Acquisition Corp, CL-A Common Stock 13F Holders
CERO Stock Ownership Activity
- # of activities:
- 1
- AVG reported price*:
- $9.91
- Current price*:
- -99.88%($0.01)
1 value investing guru has made changes to the Phoenix Biotech Acquisition Corp, CL-A Common Stock (CERO) position according to the gurus' 2022 Q1 SEC quarterly report(s). CERO has been completely sold out by 1 guru(s)
Which gurus or hedge funds bought CERO in 2022 Q1?
According to the 2022 Q1 SEC filing(s) Phoenix Biotech Acquisition Corp, CL-A Common Stock (CERO) has not been purchased by any super investor.
To see more about who is investing in Phoenix Biotech Acquisition Corp, CL-A Common Stock (CERO), please go to the CERO ownership page.
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".